Clinical Study

The Effects of Body Acupuncture on Obesity: Anthropometric Parameters, Lipid Profile, and Inflammatory and Immunologic Markers

Table 2

Comparison of clinical and biochemical characteristics of participants of body group.

VariableReal groupSham group
1st sample2nd sample3rd sample1st sample2nd sample3rd sample

Weight (kg) 8 4 . 1 0 ± 1 . 6 7 8 1 . 2 3 ± 1 . 6 8 𝛼 8 1 . 2 7 ± 2 . 4 1 𝛼 , 𝛽 8 5 . 0 2 ± 1 . 7 5 8 2 . 8 1 ± 1 . 8 1 𝛼 8 4 . 9 6 ± 2 . 5 6 𝛼
Body fat (%) 3 7 . 0 0 ± 0 . 6 9 3 6 . 0 3 ± 0 . 7 𝛼 3 7 . 9 1 ± 1 . 9 1 3 7 . 0 8 ± 0 . 7 9 3 6 . 5 4 ± 0 . 8 4 𝛼 3 6 . 3 5 ± 1 . 0 1 𝛼
BMI (Kg/m2) 3 2 . 3 0 ± 0 . 5 2 3 1 . 1 7 ± 0 . 5 3 𝛼 3 0 . 9 8 ± 0 . 6 2 𝛼 , 𝛽 3 2 . 7 4 ± 0 . 5 9 3 1 . 8 7 ± 0 . 6 1 𝛼 3 1 . 7 3 ± 0 . 7 4 𝛼
WC (cm) 1 0 2 . 3 9 ± 1 . 2 8 9 5 . 1 2 ± 1 . 2 𝛼 9 2 . 9 0 ± 1 . 4 3 𝛼 , 𝛽 1 0 0 . 7 4 ± 1 . 3 6 9 6 . 6 6 ± 1 . 2 6 𝛼 9 7 . 1 6 ± 1 . 3 1 𝛼
HC (cm) 1 1 3 . 7 6 ± 1 . 0 3 1 0 6 . 5 9 ± 0 . 9 3 𝛼 1 0 5 . 8 4 ± 1 . 1 9 𝛼 , 𝛽 1 1 4 . 9 8 ± 1 . 1 8 1 1 1 . 1 0 ± 1 . 1 5 𝛼 1 1 0 . 4 0 ± 1 . 4 8 𝛼
WC/HC ratio 0 . 9 0 ± 0 . 1 0 . 8 9 ± 0 . 0 1 0 . 0 8 7 ± 0 . 0 1 0 . 8 7 ± 0 . 0 0 8 0 . 8 7 ± 0 . 0 0 7 0 . 8 8 ± 0 . 0 0 8
FBS (mg/dL) 8 4 . 4 8 ± 1 . 4 6 8 7 . 4 6 ± 1 . 3 3 8 7 . 2 7 ± 3 . 1 8 7 . 7 6 ± 2 . 5 8 8 9 . 6 4 ± 3 . 4 0 9 0 . 0 3 ± 3 . 3 7
TC (mg/dL) 1 7 3 . 5 4 ± 4 . 1 3 1 4 8 . 1 8 ± 3 . 9 2 𝛼 1 3 7 . 9 8 ± 3 . 7 1 𝛼 , 𝛽 1 7 1 . 9 6 ± 4 . 1 1 1 6 2 . 2 3 ± 3 . 7 2 𝛼 1 5 7 . 1 5 ± 3 . 8 2 𝛼
TG (mg/dL) 1 1 2 . 4 8 ± 6 . 2 4 9 2 . 5 1 ± 4 . 4 0 𝛼 8 7 . 6 9 ± 4 . 5 5 𝛼 , 𝛽 1 2 3 . 5 8 ± 5 . 8 1 2 2 . 9 7 ± 5 . 6 8 1 0 8 . 7 6 ± 6 . 3 7 𝛼 , 𝛽
HDL-C (mg/dL) 4 2 . 6 0 ± 0 . 9 9 3 8 . 5 1 ± 0 . 8 8 𝛼 5 4 . 3 3 ± 2 . 9 6 𝛼 , 𝛽 4 1 . 6 5 ± 1 . 0 6 3 8 . 1 6 ± 0 . 9 4 𝛼 5 3 . 0 5 ± 3 . 0 1 𝛼 , 𝛽
LDL-C (mg/dL) 1 0 8 . 1 9 ± 3 . 4 4 9 1 . 3 4 ± 3 . 4 8 𝛼 7 4 . 5 0 ± 3 . 6 0 𝛼 , 𝛽 1 0 7 . 4 6 ± 3 . 0 5 9 9 . 9 2 ± 2 . 8 9 𝛼 9 3 . 2 7 ± 3 . 1 2 𝛼 , 𝛽
Anti-HSP27 0 . 3 7 ( 0 . 3 2 - 0 . 4 1 ) 0 . 3 3 ( 0 . 2 9 - 0 . 3 7 ) 𝛼 0 . 3 1 ( 0 . 2 8 - 0 . 3 4 ) 𝛼 , 𝛽 0 . 3 5 ( 0 . 3 3 - 0 . 4 1 ) 0 . 3 6 ( 0 . 3 2 - 0 . 3 9 ) 0 . 3 6 ( 0 . 3 3 - 0 . 4 1 )
Anti-HSP60 0 . 7 4 ( 0 . 6 8 - 0 . 8 6 ) 0 . 7 3 ( 0 . 6 2 - 0 . 8 0 ) 𝛼 0 . 7 0 ( 0 . 6 2 - 0 . 7 7 ) 𝛼 , 𝛽 0 . 7 2 ( 0 . 6 9 - 0 . 7 8 ) 0 . 7 3 ( 0 . 6 8 - 0 . 7 8 ) 𝛼 0 . 7 3 ( 0 . 6 7 - 0 . 7 8 )
Anti-HSP65 0 . 8 1 ( 0 . 7 3 - 0 . 9 0 ) 0 . 8 0 ( 0 . 7 3 - 0 . 8 6 ) 𝛼 0 . 7 7 ( 0 . 7 0 - 0 . 8 3 ) 𝛼 , 𝛽 0 . 8 1 ( 0 . 7 8 - 0 . 8 3 ) 0 . 8 0 ( 0 . 7 7 - 0 . 8 4 ) 0 . 8 0 ( 0 . 7 7 - 0 . 8 4 )
Anti-HSP70 0 . 5 9 ( 0 . 5 5 - 0 . 6 7 ) 0 . 5 6 ( 0 . 5 2 - 0 . 6 4 ) 𝛼 0 . 5 4 ( 0 . 5 0 - 0 . 6 0 ) 𝛼 , 𝛽 0 . 6 1 ( 0 . 5 7 - 0 . 6 6 ) 0 . 6 0 ( 0 . 5 7 - 0 . 6 5 ) 0 . 6 1 ( 0 . 5 6 - 0 . 6 6 )
hs-CRP (mg/dL) 1 . 7 8 ( 1 . 1 5 - 3 . 0 6 ) 1 . 3 ( 1 . 3 - 3 . 0 ) 0 . 8 ( 0 . 2 3 - 1 . 4 ) 𝛼 , 𝛽 1 . 7 9 ( 0 . 9 9 - 3 . 3 9 ) 1 . 3 ( 1 . 3 - 3 . 2 ) 1 . 1 0 ( 0 . 3 3 - 2 . 0 0 ) 𝛼 , 𝛽

R: Real; S: Sham; BMI: Body mass index; WC: waist circumference; HC: Hip circumference; FBS: Fasting blood sugar; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; DBP: diastolic blood pressure; SBP: systolic blood pressure. Values are expressed as mean ± SEM, or median and interquartile range. 𝛼 means significant changes in comparison with first sample and 𝛽 means significant changes in comparison with second sample.